Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169568 · ClinicalTrials.gov registry record
Osteogenesis Imperfecta Blood Pressure Study
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT04169568: Completed study, sponsored by Nemours Children's Clinic.
NCT04169568 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04169568 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Osteogenesis Imperfecta (OI) is a genetic disorder caused by mutations to the alpha-1 or alpha-2 chain of type I collagen. Clinically, the disorder is characterized by bones that fracture easily, often from little or no apparent trauma. There is no information about Some institutions perform blood pressure monitoring on these patients with a cuff, while other institutions avoid this method due to concern for fracture. Instead, they use alternative forms of monitoring such as an arterial line. These methods come with their own risks, including clotting, decreased perfusion, and pain. In addition, arterial lines require intensive (and more expensive) monitoring in a pediatric intensive care unit due to risk of dislodgement and rapid blood loss. These blood pressure monitoring recommendations for patients with OI do not appear to be based on strong evidence. Anecdotally, some patients and healthcare professionals report hearing about individuals with OI who have suffered fractures from blood pressure cuffs. However, this is not well documented in the medical literature. Regular and accurate blood pressure monitoring is particularly important in the postoperative period, due to blood loss and fluid shifts, as well as utilization of advanced pain management techniques that can potentially impact blood pressure.
Primary Outcome
Cuff blood pressure measurements obtained without injury to patient with Osteogenesis Imperfecta
Interventions
- PROCEDURE Manual cuff blood pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2025-01-04 |
What the finished NCT04169568 record still lists
NCT04169568 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Manual cuff blood pressure is the first listed.
NCT04169568 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04169568 about?
NCT04169568 is a clinical study titled "Osteogenesis Imperfecta Blood Pressure Study". Osteogenesis Imperfecta (OI) is a genetic disorder caused by mutations to the alpha-1 or alpha-2 chain of type I collagen. Clinically, the disorder is characterized by bones that fracture easily, often from little or no apparent trauma. There is no information about Some institutions perform blood p...
What is the current status of trial NCT04169568?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2019-11-15. Estimated completion is 2025-01-04.
What interventions are being tested in trial NCT04169568?
The interventions under investigation include: Manual cuff blood pressure (PROCEDURE).
Who is sponsoring clinical trial NCT04169568?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI